On the mechanism of poly(methacrylic acid -co- methyl methacrylate)-induced angiogenesis: Gene expression analysis of dTHP-1 cells

Biomaterials

Volumn 32, Issue 34, 2011, Pages 8957-8967

  Fitzpatrick, Lindsay E ^a,c   Chan, Josephine W Y ^b   Sefton, Michael V ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Angiogenesis; Cytokines; Gene expression; Macrophage; Methacrylic acid; Osteopontin

Indexed keywords

ANGIOGENESIS; CYTOKINES; GENE EXPRESSION ANALYSIS; GRAND CHALLENGE; IN-VIVO; MACROPHAGE-LIKE CELLS; METHACRYLIC ACIDS; METHYL METHACRYLATES; OSTEOPONTIN; QUANTITATIVE REAL TIME PCR; WOUND CLOSURE; WOUND HEALING;

BIOCOMPATIBILITY; ESTERS; MACROPHAGES; MOLECULES; POLYACRYLATES; POLYMERASE CHAIN REACTION;

GENE EXPRESSION;

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR B; POLY(METHACRYLIC ACID CO METHYL METHACRYLATE); POLY(METHYL METHACRYLATE); TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WOUND HEALING;

BONE CEMENTS; CELL LINE; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; METHYLMETHACRYLATE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOPONTIN; POLYMETHYL METHACRYLATE; RNA, MESSENGER;

EID: 80053095412     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.021     Document Type: Article

References (56)

1. Williams D.F. On the nature of biomaterials. Biomaterials 2009, 30(30):5897-5909.
2. Li Y., Schutte R.J., Abu-Shakra A., Reichert W.M. Protein array method for assessing in vitro biomaterial-induced cytokine expression. Biomaterials 2005, 26(10):1081-1085.
3. Jones J.A., Chang D.T., Meyerson H., Colton E., Kwon I.K., Matsuda T., et al. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomedical Materials Research Part A 2007, 83(3):585-596.
4. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol. 2008, 20(2):86-100.
5. Anand S., Cheresh D.A. MicroRNA-mediated regulation of the angiogenic switch. Curr Opin Hematol. 2011, 18(3):171-176.
6. Fantin A., Vieira J.M., Gestri G., Denti L., Schwarz Q., Prykhozhij S., et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010, 116(5):829-840.
7. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Muller W., et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol. 2010, 184(7):3964-3977.
8. Goren I., Allmann N., Yogev N., Schurmann C., Linke A., Holdener M., et al. A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am J Pathol. 2009, 175(1):132-147.
9. Diez-Roux G., Lang R.A. Macrophages induce apoptosis in normal cells in vivo. Development 1997, 124(18):3633-3638.
10. Eckhaus A.A., Fish J.S., Skarja G., Semple J.L., Sefton M.V. A preliminary study of the effect of poly(methacrylic acid-co-methyl methacrylate) beads on angiogenesis in rodent skin grafts and the quality of the panniculus carnosus. Plast Reconstr Surg. 2008, 122(5):1361-1370.
11. Martin D., Semple J., Sefton M.V. Poly(methacrylic acid-co-methyl methacrylate) beads promote vascularization and wound repair in diabetic mice. J Biomed Mater Res A 2010, 93(2):484-492.
12. Xia Z., Triffitt J. A review on macrophage responses to biomaterials. Biomed Mater 2006, 1(1):R1-R9.
13. Singer A.J., Clark R.A. Cutaneous wound healing. N Engl J Med. 1999, 341(10):738-746.
14. Liaw L., Birk D.E., Ballas C.B., Whitsitt J.S., Davidson J.M., Hogan B.L. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest. 1998, 101(7):1468-1478.
15. Lenga Y., Koh A., Perera A.S., McCulloch C.A., Sodek J., Zohar R. Osteopontin expression is required for myofibroblast differentiation. Circ Res. 2008, 102(3):319-327.
16. Sharma A., Singh A.K., Warren J., Thangapazham R.L., Maheshwari R.K. Differential regulation of angiogenic genes in diabetic wound healing. J Invest Dermatol. 2006, 126(10):2323-2331.
17. Dai J., Peng L., Fan K., Wang H., Wei R., Ji G., et al. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 2009, 28(38):3412-3422.
18. Tsai A.T., Rice J., Scatena M., Liaw L., Ratner B.D., Giachelli C.M. The role of osteopontin in foreign body giant cell formation. Biomaterials 2005, 26(29):5835-5843.
19. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000, 6(4):389-395.
20. Grimstad O., Sandanger O., Ryan L., Otterdal K., Damaas J.K., Pukstad B., et al. Cellular sources and inducers of cytokines present in acute wound fluid. Wound Repair Regen 2011, 19(3):337-347.
21. Carmi Y., Voronov E., Dotan S., Lahat N., Rahat M.A., Fogel M., et al. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol. 2009, 183(7):4705-4714.
22. Restivo T.E., Mace K., Harken A.H., Young D. Application of the chemokine CXCL12 expression plasmid restores wound healing to near normal in a diabetic mouse model. J Trauma 2010, 69(2):392-398.
23. Gallagher K.A., Liu Z.J., Xiao M., Chen H., Goldstein L.J., Buerk D.G., et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest. 2007, 117(5):1249-1259.
24. Rieu I., Powers S.J. Real-time quantitative RT-PCR: design, calculations, and statistics. Plant Cell 2009, 21(4):1031-1033.
25. Butler M.J., Sefton M.V. Poly(butyl methacrylate-co-methacrylic acid) tissue engineering scaffold with pro-angiogenic potential in vivo. J Biomed Mater Res A 2007, 82(2):265-273.
26. Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 1991, 47(1):22-31.
27. Vaddi K., Newton R.C. Comparison of biological responses of human monocytes and THP-1 cells to chemokines of the intercrine-beta family. J Leukoc Biol. 1994, 55(6):756-762.
28. Mori R., Shaw T.J., Martin P. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med. 2008, 205(1):43-51.
29. Giachelli C.M., Lombardi D., Johnson R.J., Murry C.E., Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol. 1998, 152(2):353-358.
30. Scatena M., Liaw L., Giachelli C.M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol. 2007, 27(11):2302-2309.
31. Scatena M., Almeida M., Chaisson M.L., Fausto N., Nicosia R.F., Giachelli C.M. NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol. 1998, 141(4):1083-1093.
32. Krause S.W., Rehli M., Kreutz M., Schwarzfischer L., Paulauskis J.D., Andreesen R. Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol. 1996, 60(4):540-545.
33. Bruemmer D., Collins A.R., Noh G., Wang W., Territo M., Arias-Magallona S., et al. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest. 2003, 112(9):1318-1331.
34. Nakamachi T., Nomiyama T., Gizard F., Heywood E.B., Jones K.L., Zhao Y., et al. PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes. Diabetes 2007, 56(6):1662-1670.
35. Ogawa D., Stone J.F., Takata Y., Blaschke F., Chu V.H., Towler D.A., et al. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Circ Res. 2005, 96(7):e59-e67.
36. Wai P.Y., Guo L., Gao C., Mi Z., Guo H., Kuo P.C. Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation. Surgery 2006, 140(2):132-140.
37. Renault M.A., Roncalli J., Tongers J., Thorne T., Klyachko E., Misener S., et al. Sonic hedgehog induces angiogenesis via Rho kinase-dependent signaling in endothelial cells. J Mol Cell Cardiol. 2010, 49(3):490-498.
38. Singh K., Balligand J.L., Fischer T.A., Smith T.W., Kelly R.A. Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase. J Biol Chem. 1995, 270(47):28471-28478.
39. Xie Z., Pimental D.R., Lohan S., Vasertriger A., Pligavko C., Colucci W.S., et al. Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species. J Cell Physiol. 2001, 188(1):132-138.
40. Popova A., Kzhyshkowska J., Nurgazieva D., Goerdt S., Gratchev A. Pro- and anti-inflammatory control of M-CSF-mediated macrophage differentiation. Immunobiology 2011, 216(1-2):164-172.
41. Mosser D.M. The many faces of macrophage activation. J Leukoc Biol. 2003, 73(2):209-212.
42. Rosen E.M., Liu D., Setter E., Bhargava M., Goldberg I.D. Interleukin-6 stimulates motility of vascular endothelium. EXS 1991, 59:194-205.
43. Fràter-Schröder M., Risau W., Hallmann R., Gautschi P., Böhlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci U S A 1987, 84(15):5277-5281.
44. Sato N., Goto T., Haranaka K., Satomi N., Nariuchi H., Mano-Hirano Y., et al. Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J Natl Cancer Inst. 1986, 76(6):1113-1121.
45. Sainson R.C., Johnston D.A., Chu H.C., Holderfield M.T., Nakatsu M.N., Crampton S.P., et al. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 2008, 111(10):4997-5007.
46. Skarja G.A., Brown A.L., Ho R.K., May M., Sefton M. The effect of a hydroxamic acid-containing polymer on active matrix metalloproteinases. Biomaterials 2009, 30(10):1890-1897.
47. Burgess E., Hollinger J., Bennett S., Schmitt J., Buck D., Shannon R., et al. Charged beads enhance cutaneous wound healing in rhesus non-human primates. Plast Reconstr Surg. 1998, 102(7):2395-2403.
48. Tawil N.J., Connors D., Gies D., Bennett S., Gruskin E., Mustoe T. Stimulation of wound healing by positively charged dextran beads depends upon clustering of beads and cells in close proximity to the wound. Wound Repair Regen 1999, 7(5):389-399.
49. Wu L., Mockros N.E., Casperson M.E., Gruskin E.A., Ladin D.A., Roth S.I., et al. Effects of electrically charged particles in enhancement of rat wound healing. J Surg Res. 1999, 85(1):43-50.
50. Connors D., Gies D., Lin H., Gruskin E., Mustoe T.A., Tawil N.J. Increase in wound breaking strength in rats in the presence of positively charged dextran beads correlates with an increase in endogenous transforming growth factor-beta1 and its receptor TGF-betaRI in close proximity to the wound. Wound Repair Regen 2000, 8(4):292-303.
51. Sasaki A., Mueller R.V., Xi G., Sipe R., Buck D., Hollinger J. Mast cells: an unexpected finding in the modulation of cutaneous wound repair by charged beads. Plast Reconstr Surg. 2003, 111(4):1446-1453.
52. Mustoe T.A., Weber D.A., Krukowski M. Enhanced healing of cutaneous wounds in rats using beads with positively charged surfaces. Plast Reconstr Surg. 1992, 89(5):891-897.
53. Sanders J.E., Cassisi D.V., Neumann T., Golledge S.L., Zachariah S.G., Ratner B.D., et al. Relative influence of polymer fiber diameter and surface charge on fibrous capsule thickness and vessel density for single-fiber implants. J Biomed Mater Res. A 2003, 65(4):462-467.
54. Sanders J.E., Lamont S.E., Karchin A., Golledge S.L., Ratner B.D. Fibro-porous meshes made from polyurethane micro-fibers: effects of surface charge on tissue response. Biomaterials 2005, 26(7):813-818.
55. Brauker J.H., Carr-Brendel V.E., Martinson L.A., Crudele J., Johnston W.D., Johnson R.C. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res. 1995, 29(12):1517-1524.
56. Madden L.R., Mortisen D.J., Sussman E.M., Dupras S.K., Fugate J.A., Cuy J.L., et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A 2010, 107(34):15211-15216.